Everest Medicines Limited (FRA:6HN)
Germany
· Delayed Price · Currency is EUR 4.860
+0.040 (0.83%)
At close: Dec 4, 2025
Everest Medicines Market Cap
Everest Medicines has a market cap or net worth of €1.77 billion as of December 5, 2025. Its market cap has increased by 30.03% in one year.
Market Cap
1.77B
Enterprise Value
1.66B
Revenue
101.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.86
Market Cap Chart
Since October 9, 2020, Everest Medicines's market cap has decreased from 2.25B to 1.77B, a decrease of -21.59%. That is a compound annual growth rate of -4.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 1.77B | -8.66% |
| Dec 31, 2024 | 1.94B | 150.05% |
| Dec 29, 2023 | 775.42M | 20.25% |
| Dec 30, 2022 | 644.85M | -44.62% |
| Dec 31, 2021 | 1.16B | -44.37% |
| Dec 31, 2020 | 2.09B | -7.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.06B |
| Siemens Aktiengesellschaft | 175.97B |
| Allianz SE | 141.37B |
| Deutsche Telekom AG | 131.00B |
| Siemens Energy AG | 97.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.46B |
| Rheinmetall AG | 68.36B |
| Deutsche Bank Aktiengesellschaft | 59.35B |